Cytology And HPV Testing Market Trend & Forecast

Market Insights

The cytology and HPV testing market is estimated to grow from USD 9.37 billion in 2022 and is likely to grow at a CAGR of 6.0% during 2023-2028 to reach USD 13.34 billion by 2028.

Wish to get a Free Sample? Register Here.

What are cytology and HPV testing?

Cytology and HPV Testing deal with test procedures to detect changes in cells, whether these changes are caused by a disease or other reasons. This testing can be done using different methods such as HPVs, cytological assay, and DNA detection, among others. Cytology studies & analyzes diseases on a cellular level, whereas HPV is a set of over 100 types of similar viruses that cause STIs (Sexually Transmitted Infections) like warts, and in some cases, even cause cancer. Human papillomavirus (HPV) test is generally carried out to determine the high risk of HPV infection that can cause the formation of cancerous cells on the cervix.

Covid-19 Impact Analysis

The outbreak of COVID-19 moderately affected the cytology and HPV testing industry. The healthcare industry is currently facing major challenges as it is unable to provide proper medical facilities to meet the ever-growing coronavirus patient pool. With the stringent imposition of lockdown and social distance regulations, there were limited check-ups of women suffering from sexually transmitted diseases.

During the pandemic period in 2020, around 342,000 women lost their lives due to cervical cancer. Thus, a poor healthcare system due to limited medical professionals and funding affected the market growth.

Market Drivers

The cytology and HPV testing market is driven by a host of factors, some of which are noted below:

• The advent of highly sensitive & specific assays as well as advanced analyzing instruments for cervical cancer screening.
• Also, the high incidence rate of high-risk types of HPV coupled with the weakening immune system of the population.
• Rising awareness regarding cytology and HPV testing affected the market positively.
• Technological advancements in healthcare are promoting people to opt for high-accuracy diagnostic tests.

To Get the full scope of the report, Register Here.

Segment Analysis

End-Use Trends

The market has been divided into hospitals, clinics, and research institutes. The hospital segment held a significant market share in 2022 & is expected to grow at a robust CAGR during the forecast period. 

Cytology and HPV testing in hospitals are primarily used for diagnosing different kinds of diseases. It helps to detect cervical cancer, breast cancer, skin cancer, etc. and hospitals offer all the required medical equipment and qualified healthcare professionals, thereby augmenting the segment growth.

Regional Insight

North America accounted for the largest share in 2022 and is expected to grow at a significant CAGR during the review period.

Want to know which region offers the best growth opportunities? Register Here.

The market growth is mainly propelled by a high incidence of cervical cancer & HPV infections and an increasing number of awareness programs initiated by governments regarding the availability of technologically advanced diagnostic test kits, further bolstering the regional market growth.

Asia-Pacific is expected to grow at the highest CAGR during the review on account of the growth of the major end-use industries. This growth is mainly attributed to the presence of a large cancer patient pool in China, India, and Japan.

Also, increasing awareness regarding gynecology diseases among women and surging funds for healthcare facilities further proliferate the regional market expansion.

Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The market is segmented into the following categories:

By Product

• Systems
• Assay Kits
• Services

By End-Use

• Hospitals
• Clinics
• Research Institutes

By Region

• North America (Country Analysis: The USA, Canada, and Mexico),
• Europe (Country Analysis: Germany, France, The UK, Russia, and the Rest of Europe),
• Asia-Pacific (Country Analysis: China, India, Australia, South Korea, and the Rest of Asia-Pacific),
• Rest of the World (Country Analysis: Saudi Arabia, Brazil, and Others).

Key Players

The following are some of the key players operating in the market are-

• Abbott (US)
• Arbor Vita (US)
• Becton Dickinson (US)
• Cepheid (US)
• Roche (Switzerland)
• Fujirebio (Japan)
• Hologic (US)
• OncoHealth (US)
• QIAGEN (Germany)
• F. Hoffmann-La Roche AG (Switzerland)

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
What Deliverables Will You Get in this Report?

Target Audience

The target audience of the cytology and HPV testing market includes-

• Vendors
• Manufacturers
• Distributors
• Organizations
• Government Bodies

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Option

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.